Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Ixabepilone for High Risk Localized Prostate Cancer
NCT00828308Phase 2Completed
- Sponsor
- Brown University
- Start
- Feb 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in prostate cancer (PCa), sponsored by Brown University. Started Feb 2009; status: completed.
02
Drugs
ixabepilone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00828308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828308.